Tower Research Capital (TRC)’s Daxor DXR Stock Holding History
Bought
Maintained
Sold
Other funds holding DXR
BPI
NCNMGF
BFCFSI
Tower Research Capital (TRC)'s DXR Position: Q2 2026 in Review
Tower Research Capital (TRC) increased its Daxor (DXR) stake by 180% in Q2 2026, buying an estimated $1.98K and bringing the position to 305 shares worth $3.14K. The position accounts for ﹤0.01% of the portfolio, ranked #4572.
Tower Research Capital (TRC) first reported a position in DXR in Q3 2013 and has held it in 25 quarters since. The position peaked at $29K in Q3 2022. 16 funds tracked by Wall St. Rank hold DXR as of Q2 2026.
- Tower Research Capital (TRC) held 305 shares of Daxor worth $3.14K as of Q2 2026.
- Tower Research Capital (TRC) bought 196 Daxor shares in Q2 2026, an estimated $1.98K.
- Daxor made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4572 holding.
- Tower Research Capital (TRC) first reported a position in Daxor in Q3 2013 and has held it in 25 quarters since.
- Tower Research Capital (TRC)'s Daxor position peaked at $29K in Q3 2022.
- 16 funds tracked by Wall St. Rank held Daxor as of Q2 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.